SCL

Stepan Co Consumer Staples Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics Russell 3000
$69.61Close $1.9BMarket cap $41.04 – $69.9952-week range Late-januaryNext report · estimated

Highlights

Strengths

  • In a stage-2 uptrend all 8 trend conditions pass
  • Leading the market RS 84 · stronger than 84% of stocks over 12 months
  • Near its high 1% below its 52-week high
  • Earnings growing EPS +102% year on year, faster than the quarter before (+412 pts)

Cautions

  • Extended 4.0 ATR above its 50-day average

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 5, 2026
Off 12-month high 1%
1wk up 8.9% price change
1mo up 11.6% price change
12-month return up 67% market up 11% · its own up 52%
F-score 5 / 9 Mixed
Altman Z 2.98 Moderate risk
P/E 40.5× price / earnings
PEG — P/E / EPS growth
P/B 1.5× price / book
Earnings yield up 3.7% EBIT / enterprise value
Cheaper than 55% of the market · around average
Revenue growth up 7% year on year
EPS growth up 102% latest quarter · +412 pts
Sales growth up 15% latest quarter · +13 pts
ROE up 4% return on equity
Free cash margin up 1% $25.4M FCF
D/E 0.27 long-term debt / equity
Net debt / EBITDA 1.0×
Interest cover 2.6×EBIT / interest
Piotroski tests
  • profitability slipped from last year
  • took on more long-term debt
  • issued more shares
  • gross margin narrowed
  • profitable on its assets
  • generating cash from operations
  • profits backed by cash
  • short-term liquidity improved
  • assets working harder

Repair signals

  • Revenue reaccelerating (-6% then +7%)

Trade setup

ATR% 2.6% $1.84 a day · 2×ATR $65.93
RS 84 / 99 vs the universe
Trend 8 / 8 trend template
Relative volume 1.6× vs 50-day average
Up/down volume 1.00 50 sessions
Implied move — no scheduled report
Trend template · 8 of 8

Screen verdict

1 of 3 screens
  • Stage 2 Leader in mixed conditions
    • RS 84
    • Trend 8/8
    • Off 12-month high 1%
    • EPS growth +102% (accel +412 pts)
    • Sales growth +15% (accel +13 pts)
    • Altman Z 2.98 (moderate risk)

Warning signs

none flagged
  • No restatement or impairment
  • Equity positive
  • Interest covered
  • No material dilution
  • Profits tracking cash
  • Margins and revenue not shrinking
Last reported Oct 28, 2026
Results reaction Oct 28, 2026+7% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $2.3B +7% on FY2024
$0 $5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $1.9B FY2021 · $2.3B FY2022 · $2.8B FY2023 · $2.3B FY2024 · $2.2B FY2025 · $2.3B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $46.9M -7% on FY2024
$0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $126.8M FY2021 · $137.8M FY2022 · $147.2M FY2023 · $40.2M FY2024 · $50.4M FY2025 · $46.9M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $25.4M -35% on FY2024
-$200M $0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $109.4M FY2021 · -$122.3M FY2022 · -$140.8M FY2023 · -$85.5M FY2024 · $39.3M FY2025 · $25.4M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 12%
  • Net 2%
  • Free cash 1%
-10% 0% 25% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 21% · Net 7% · Free cash 6% FY2021 · Gross 17% · Net 6% · Free cash -5% FY2022 · Gross 15% · Net 5% · Free cash -5% FY2023 · Gross 12% · Net 2% · Free cash -4% FY2024 · Gross 12% · Net 2% · Free cash 2% FY2025 · Gross 12% · Net 2% · Free cash 1%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $208.3M net debt
  • Cash
  • Long-term debt
$0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $349.9M · Long-term debt $160.8M FY2021 · Cash $159.2M · Long-term debt $322.9M FY2022 · Cash $173.8M · Long-term debt $455.0M FY2023 · Cash $129.8M · Long-term debt $401.2M FY2024 · Cash $99.7M · Long-term debt $332.6M FY2025 · Cash $132.7M · Long-term debt $341.0M
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 27.30m +2.4% since FY2020
27.30m 26.66m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 26.66m FY2021 · 26.76m FY2022 · 26.84m FY2023 · 27.01m FY2024 · 27.16m FY2025 · 27.30m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $1.9B $2.3B $2.8B $2.3B $2.2B $2.3B
Gross margin 21% 17% 15% 12% 12% 12%
Operating income $171.5M $170.8M $207.3M $58.6M $70.5M $78.5M
Net income $126.8M $137.8M $147.2M $40.2M $50.4M $46.9M
Net margin 7% 6% 5% 2% 2% 2%
Earnings per share $5.45 $5.92 $6.38 $1.75 $2.20 $2.05
Free cash flow $109.4M -$122.3M -$140.8M -$85.5M $39.3M $25.4M
Free cash margin 6% -5% -5% -4% 2% 1%
Cash $349.9M $159.2M $173.8M $129.8M $99.7M $132.7M
Long-term debt $160.8M $322.9M $455.0M $401.2M $332.6M $341.0M
Shareholders' equity $986.7M $1.1B $1.2B $1.2B $1.2B $1.2B
Shares outstanding 26.66m 26.76m 26.84m 27.01m 27.16m 27.30m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 5, 2026 Quarterly ↗ Jun 30, 2026 36d
May 6, 2026 Quarterly ↗ Mar 31, 2026 36d
Feb 26, 2026 Annual ↗ Dec 31, 2025 57d
Nov 5, 2025 Quarterly ↗ Sep 30, 2025 36d
Aug 6, 2025 Quarterly ↗ Jun 30, 2025 37d
May 7, 2025 Quarterly ↗ Mar 31, 2025 37d
Feb 27, 2025 Annual ↗ Dec 31, 2024 58d
Nov 6, 2024 Quarterly ↗ Sep 30, 2024 37d
Aug 8, 2024 Quarterly ↗ Jun 30, 2024 39d
May 8, 2024 Quarterly ↗ Mar 31, 2024 38d
Feb 29, 2024 Annual ↗ Dec 31, 2023 60d
Nov 2, 2023 Quarterly ↗ Sep 30, 2023 33d

Current reports